Back to the main directory
EarningsReview / Equity
- SVITZER: coverage dropped by BNP Paribas Exane
- Aurobindo Pharma (ARBP IN) by HSBC
- Roche CMD feedback: relief for QIAGEN, signals of change in marketing strategy for multiplexing panels by BNP Paribas Exane
- LONZA: coverage dropped by BNP Paribas Exane
- SARTORIUS PREF: coverage dropped by BNP Paribas Exane
- Kuaishou Technology (1024 HK) by HSBC
- In the Flow by BNP Paribas Exane
- Market expectations may be too high going into F1Q results by BNP Paribas Exane
- Feeling the press on margins, but comps still in the Zone by BNP Paribas Exane
- Announcement of CFO resignation by BNP Paribas Exane
- Info Edge India (INFOE IN) by HSBC
- CMD preview: larger transformation ahead? by BNP Paribas Exane
- Admin Moves to Make Auto Loan Interest Deductible; End Cali ICE Ban by BNP Paribas Exane
- 37 stocks, 222 charts, 555 questions by BNP Paribas Exane
- Initiate coverage of Henkel ADR by BNP Paribas Exane
- Questions for Animal Health management teams by BNP Paribas Exane
- Lanxess - EARNINGS RECOVERY AMID WEAK MARKET ENVIRONMENT by Equita Sim
- H225 results and 15 questions for management by BNP Paribas Exane
- The merger decision will be taken to the Cabinet by BNP Paribas Exane
- Q1 Results: Dividend suspended, Earnings guidance reiterated by BNP Paribas Exane
- Derichebourg - Des résultats conformes à nos attentes by MidCap Partners
- Pierre & Vacances SA - Scénario annuel confirmé by MidCap Partners
- Mixed read-x from Web Travel FY 25 results by BNP Paribas Exane
- Derichebourg - Results in line with our expectations by MidCap Partners
- STEEL US, X, CLF, MT, RIO, BHP by BNP Paribas Exane